Filing Details
- Accession Number:
- 0001127602-10-014480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-17 13:00:00
- Reporting Period:
- 2010-05-14
- Filing Date:
- 2010-05-17
- Accepted Time:
- 2010-05-17 15:12:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181174 | Caroline Dorsa | Biogen Idec Inc. 14 Cambridge Center Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-14 | 1 | $50.21 | 1,153 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2010-05-14 | 94 | $51.17 | 1,247 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2010-05-14 | 100 | $51.22 | 1,347 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.